Sarah M Labuda1, Yanling Huo2, Deborah Kacanek2, Kunjal Patel2,3, Krista Huybrechts4, Jennifer Jao5, Christiana Smith6, Sonia Hernandez-Diaz2, Gwendolyn Scott7, Sandra Burchett8, Fatima Kakkar9, Ellen G Chadwick5, Russell B Van Dyke1. 1. Department of Pediatrics, Tulane University School of Medicine, New Orleans, Louisiana, USA. 2. Center for Biostatistics in AIDS Research,Boston, Massachusetts, USA. 3. Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA. 4. Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts, USA. 5. Department of Pediatrics, Northwestern Feinberg School of Medicine, Chicago, Illinois, USA. 6. Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA. 7. Department of Pediatrics, University of Miami Miller School of Medicine, Miami, Florida, USA. 8. Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA. 9. Department of Pediatrics, Université de Montréal, Montreal, Canada.
Abstract
BACKGROUND: Studies from multiple countries have suggested impaired immunity in perinatally human immunodeficiency virus (HIV)-exposed uninfected children (HEU), with elevated rates of all-cause hospitalization and infections. We estimated and compared the incidence of all-cause hospitalization and infection-related hospitalization in the first 2 years of life among HEU and HIV-unexposed uninfected children (HUU) in the United States. Among HEU, we evaluated associations of maternal HIV disease-related factors during pregnancy with risk of child hospitalization. METHODS: HEU data from subjects enrolled in the Surveillance Monitoring for Antiretroviral Therapy Toxicities Study (SMARTT) cohort who were born during 2006-2017 were analyzed. HUU comparison data were obtained from the Medicaid Analytic Extract database, restricted to states participating in SMARTT. We compared rates of first hospitalization, total hospitalizations, first infection-related hospitalization, total infection-related hospitalizations, and mortality between HEU and HUU using Poisson regression. Among HEU, multivariable Poisson regression models were fitted to evaluate associations of maternal HIV factors with risk of hospitalization. RESULTS: A total of 2404 HEU and 3 605 864 HUU were included in the analysis. HEU children had approximately 2 times greater rates of first hospitalization, total hospitalizations, first infection-related hospitalization, and total infection-related hospitalizations compared with HUUs. There was no significant difference in mortality. Maternal HIV disease factors were not associated with the risk of child infection or hospitalization. CONCLUSIONS: Compared with HUU, HEU children in the United States have higher rates of hospitalization and infection-related hospitalization in the first 2 years of life, consistent with studies in other countries. Closer monitoring of HEU infants for infection and further elucidation of immune mechanisms is needed.
BACKGROUND: Studies from multiple countries have suggested impaired immunity in perinatally human immunodeficiency virus (HIV)-exposed uninfected children (HEU), with elevated rates of all-cause hospitalization and infections. We estimated and compared the incidence of all-cause hospitalization and infection-related hospitalization in the first 2 years of life among HEU and HIV-unexposed uninfected children (HUU) in the United States. Among HEU, we evaluated associations of maternal HIV disease-related factors during pregnancy with risk of child hospitalization. METHODS: HEU data from subjects enrolled in the Surveillance Monitoring for Antiretroviral Therapy Toxicities Study (SMARTT) cohort who were born during 2006-2017 were analyzed. HUU comparison data were obtained from the Medicaid Analytic Extract database, restricted to states participating in SMARTT. We compared rates of first hospitalization, total hospitalizations, first infection-related hospitalization, total infection-related hospitalizations, and mortality between HEU and HUU using Poisson regression. Among HEU, multivariable Poisson regression models were fitted to evaluate associations of maternal HIV factors with risk of hospitalization. RESULTS: A total of 2404 HEU and 3 605 864 HUU were included in the analysis. HEU children had approximately 2 times greater rates of first hospitalization, total hospitalizations, first infection-related hospitalization, and total infection-related hospitalizations compared with HUUs. There was no significant difference in mortality. Maternal HIV disease factors were not associated with the risk of child infection or hospitalization. CONCLUSIONS: Compared with HUU, HEU children in the United States have higher rates of hospitalization and infection-related hospitalization in the first 2 years of life, consistent with studies in other countries. Closer monitoring of HEU infants for infection and further elucidation of immune mechanisms is needed.
Authors: Marisa M Mussi-Pinhata; Fabrizio Motta; Laura Freimanis-Hance; Ricardo de Souza; Edgardo Szyld; Regina C M Succi; Celia D C Christie; Maria J Rolon; Mariana Ceriotto; Jennifer S Read Journal: Int J Infect Dis Date: 2010-05-08 Impact factor: 3.623
Authors: Yanling Huo; Kunjal Patel; Gwendolyn B Scott; Russell B Van Dyke; George K Siberry; Sandra K Burchett; William T Shearer Journal: J Allergy Clin Immunol Date: 2017-03-06 Impact factor: 10.793
Authors: E Ono; A M Nunes dos Santos; R C de Menezes Succi; D M Machado; D S A de Angelis; R Salomão; E G Kallás; M I de Moraes-Pinto Journal: Braz J Med Biol Res Date: 2008-08 Impact factor: 2.590
Authors: Russell B Van Dyke; Ellen Gould Chadwick; Rohan Hazra; Paige L Williams; George R Seage Journal: Front Immunol Date: 2016-05-23 Impact factor: 7.561
Authors: Christiana Smith; Emilie Jalbert; Volia de Almeida; Jennifer Canniff; Laurel L Lenz; Marisa M Mussi-Pinhata; Rachel A Cohen; Qilu Yu; Fabiana R Amaral; Jorge Pinto; Jorge O Alarcon; George Siberry; Adriana Weinberg Journal: Front Immunol Date: 2017-04-24 Impact factor: 7.561
Authors: Sepideh Dolatshahi; Audrey L Butler; Mark J Siedner; Joseph Ngonzi; Andrea G Edlow; Julian Adong; Madeleine F Jennewein; Caroline Atyeo; Ingrid V Bassett; Drucilla J Roberts; Douglas A Lauffenburger; Galit Alter; Lisa M Bebell Journal: Clin Infect Dis Date: 2022-10-12 Impact factor: 20.999
Authors: Amy L Slogrove; Barbara Burmen; Mary Ann Davies; Andrew Edmonds; Elaine J Abrams; Ellen G Chadwick; Tessa Goetghebuer; Lynne M Mofenson; Mary E Paul; Claire Thorne; Paige L Williams; Marissa Vicari; Kathleen M Powis Journal: Clin Infect Dis Date: 2022-08-25 Impact factor: 20.999
Authors: Kim Anderson; Emma Kalk; Hlengiwe P Madlala; Dorothy C Nyemba; Nisha Jacob; Amy Slogrove; Mariette Smith; Max Kroon; Michael C Harrison; Brian S Eley; Andrew Boulle; Landon Myer; Mary-Ann Davies Journal: AIDS Date: 2021-05-01 Impact factor: 4.632